4
Changes in Ownership
Hepion Pharmaceuticals, Inc. Filed Acc 0001104659-20-044170
Options or other derivatives
- CEO and CSO acquired 380,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Foster Robert T · CEO and CSO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-03 | Grant or award : show line 1 in the form Stock Options | +380,000 | 389,879 | D |
Loading xslF345X03/a4.xml…